Molecular Med Tri-Con Symposia 2016

Date: 10 - 11 Mar 2016 Location: Hilton San Francisco Union Square City: San Francisco, CA Country: USA Visit the event website for more information

Booth #16

Presentation:  Thursday, 10Mar2016 at 12:15pm

Title:  Genomic Editing, Nucleofection, and the Generation of Cell Lines for Cell-Based Assays
Gregory Alberts, Ph.D. Global Subject Matter Expert, Lonza Pharma Bioscience Solutions
Using primary cells in cell-based assays can improve the assays, which should translate more effectively into in vivo models. Lonza’s Nucleofector™ technology easily transfects primary cells, and with CRISPR, primary cells can be specifically modified at the genomic level, creating isogenic strains of specific cells that differ in only one specific aspect.